MJ GLEESON PLC

Director's Dealing • Apr 9, 2020

National Storage Mechanism | Additional information

RNS Number : 4053J

MJ Gleeson PLC

09 April 2020

MJ Gleeson Plc ("MJ Gleeson", the "Company" or the "Group")

Notification of Transactions by Directors / PCA

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, MJ Gleeson announces that it has been notified that Harwood Capital LLP, a legal person closely associated with Christopher Mills, a Director of the Company, has acquired Ordinary Shares in the Company.

Enquiries:

MJ Gleeson plc Stefan Allanson Leanne Johnson	Chief Financial Officer Head of Legal & Company Secretary	01142  612900

The information below set out in accordance with the requirement of the EU Market Abuse Regulation provides further detail.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Harwood Capital LLP
2	Reason for notification
a.	Position/Status	Person closely associated with a director
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	MJ Gleeson plc
b.	LEI	21380064K7N2W7FD6434
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary Shares of £0.02 each  ISIN: GB00BRKD9Z53
b.	Nature of the transaction	Purchase of shares
c.	Price(s) and volume(s)
	Price(s)	Volume(s)
600p	300,000
d.	Aggregated information - Aggregated Volume - Price	n/a (single transaction)
e.	Date of the transaction	8 April 2020
f.	Place of the transaction	London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHUKOURRRUSRAR